The new artificial blood vessel is more effective in the treatment of acute thrombosis

Moscow, August 10 (Xinhua) according to a recent Russian report, researchers at Tomsk University of technology, Russia, put polyglycolide into a magnetron discharge plasma for treatment, and developed a new artificial blood vessel manufacturing technology that can better treat acute thrombosis. This method is more effective and higher quality than similar technology, and the price is only one tenth of that of similar technology. The results were published in the journal. As we all know, artificial blood vessel is a kind of graft, which is used to treat acute thrombosis. When vascular function cannot be restored by drugs or surgery, the site of thrombosis should be removed and replaced by artificial blood vessels made of polycarbonate or other biocompatible materials. < / P > < p > in order to improve the survival rate of transplanted blood vessels, the technology used now is extremely complex, and the drugs are also very expensive. However, according to medical experts, there are still many deficiencies in the current artificial vascular technology and its functional characteristics. According to yevgeni bolbasov, a researcher at the plasma mixing system Laboratory of Tomsk University of technology, the main advantage of the artificial blood vessel they studied is that the outer layer of the blood vessel can be softened by water, making it easy for the artificial blood vessel to survive in the body. The inner layer of the artificial blood vessel can not be softened by water, so as to ensure the best flow of blood. < / P > < p > it is reported that researchers from Tomsk University of technology proposed for the first time that polyglycolide treated by magnetron discharge plasma can be used to make artificial blood vessels. This technology can ensure that the artificial blood vessels have two key characteristics: high quality combination of materials and patient tissues and high air tightness. Sergei tverdokhlepov, director of the plasma mixing system laboratory at Tomsk University of technology, said that the unique feature of the domestic new technology is that it is simpler than the existing artificial blood vessel manufacturing methods, and the cost is only one tenth of that of similar technology. Counterpoint announced top 5 best selling models: domestic iPhone 11 tops the list

Author: zmhuaxia